The allotment for Anthem Biosciences IPO is now complete. Investors can check their status on KFin Technologies website. The ...

The IPO, which opened for subscription on 14 July and closed on 16 July, witnessed strong investor interest, particularly ...

AM, GIFT Nifty futures were trading 14 points higher at 25,260, indicating a flat to positive start for the bourses.

Anthem Biosciences' IPO ended on 16 July, with the issue booked over 60 times. Strong demand from qualified institutional ...

Monika Alcobev IPO price band has been set at ₹271 to ₹286 per share. Investors can apply for a lot of 400 shares and ...

Since this IPO was fully an OFS, the contract research, development and manufacturing company will not receive any funds, ...

Anthem Biosciences' initial public offering (IPO) was subscribed 63.86 times, largely due to strong support from qualified institutional buyers (QIBs).

Anthem Biosciences IPO oversubscribed 63.86 times, attracting strong QIB support, raising ₹1,016 crore from anchor investors.

Recent health headlines include FDA's eye safety concerns over GSK's cancer drug, escalating malnutrition rates in Gaza ...

Anthem Biosciences’ ₹3,395-crore IPO saw strong investor demand, with overall subscription at 63.86x, signaling robust interest in the pharma CDMO sector.

Anthem Biosciences' Rs 3,395 crore IPO was subscribed 63.86 times, exceeding expectations. QIBs showed strong interest, while ...

The Anthem Biosciences IPO, starting July 14, 2025, aims to raise ₹3,395 crore through an Offer for Sale of 5.96 crore shares by existing shareholders, without proceeds going to the company. Shares ...